oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Oxydolor

Stability studies of the product batches showed an out-of-specification result for active substance content, which may lead to incorrect dosing of the medicine. Potential effects: lack of treatment efficacy or overdose, complications, risk to health.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Oxydolor
Risk Level
High
Manufacturer
G.L.Pharma GmbH, Austria
Batch Number
9F119A, 9F119B
EAN Code
05909990840038
Recall Date
28.08.2020
View official statement

Important Information

What You Should Know

Recommendations

Do not use the product from batches 9F119A and 9F119B; if you have it, return the medicine to a pharmacy or consult a doctor or pharmacist.

Actions Taken

The Chief Pharmaceutical Inspector withdrew batches 9F119A and 9F119B of Oxydolor 40 mg prolonged-release tablets from the market nationwide and granted the decision immediate enforceability.

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: Stability studies of the product batches showed an out-of-specification result for active substance content, which may lead to incorrect dosing of the medicine. Potential effects: lack of treatment efficacy or overdose, complications, risk to health.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: 9F119A, 9F119B

Related

Other Recalled Products